tradingkey.logo
tradingkey.logo
Search

LB Pharmaceuticals Inc

LBRX
Add to Watchlist
37.820USD
-1.370-3.50%
Market hours 09/24, 14:33(ET)
1.08BMarket Cap
LossP/E TTM

LBRX Financials

See LB Pharmaceuticals Inc's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.

Key Financial Ratios

Market Cap
1.08B
Dividend TTM
0.00
P/E TTM
-26.36
EPS TTM
-1.43
Revenue
--
Net Profit
-63.10M
ROE
0.00%
ROA
0.00%

LB Pharmaceuticals Inc Earnings Date

Latest Release
Aug 11, 2026
EPS / Forecast
--/-2.87
Revenue / Forecast
--/--

Financial Statement Highlights

Quarterly
Quarterly+Annual
Quarterly
Annual
FY2026Q2
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
Financial Indicators
EPS
---1.71
---0.67
---0.45
---0.14
----
Net Profit
---51.60M
---19.05M
---11.47M
---3.56M
----
Operating profit
---53.91M
---22.10M
---13.87M
---5.25M
----
Net Profit
---51.60M
---19.05M
---11.47M
---3.56M
----
Current assets
2303.77%355.30M
--389.07M
--308.43M
--316.40M
--14.78M
Total current liabilities
503.28%23.56M
--10.91M
--7.44M
--6.65M
--3.91M
Total assets
1779.11%361.69M
--393.48M
--312.93M
--320.75M
--19.25M
Total liabilities
231.13%29.34M
--14.79M
--11.62M
--10.53M
--8.86M
Total equity
3099.95%332.35M
--378.69M
--301.31M
--310.22M
--10.39M
Net operating income
---37.63M
---23.29M
---18.10M
---3.37M
----
Net investment
--89.00K
---32.00K
---40.00K
---44.84M
----
Net financing
---19.00K
--93.83M
---1.17M
--303.73M
----

FAQs

What are the current assets of LB Pharmaceuticals Inc?

According to LB Pharmaceuticals Inc's FY2025 earnings report, its current assets were 308.43M, with a year-on-year change of 968.01.

What are the total assets of LB Pharmaceuticals Inc?

According to LB Pharmaceuticals Inc's FY2025 earnings report, its total assets of LB Pharmaceuticals Inc were 312.93M, with a year-on-year change of 833.18.

What are the total liabilities of LB Pharmaceuticals Inc?

According to LB Pharmaceuticals Inc's FY2025 earnings report, its total liabilities of LB Pharmaceuticals Inc were 11.62M, with a year-on-year change of -15.94.

What is the total equity of LB Pharmaceuticals Inc?

According to LB Pharmaceuticals Inc's FY2025 earnings report, its total equity of LB Pharmaceuticals Inc was 301.31M, with a year-on-year change of 1429.10.

What is the net operating income of LB Pharmaceuticals Inc?

According to LB Pharmaceuticals Inc's FY2025 earnings report, its net operating income of LB Pharmaceuticals Inc was -30.40M, with a year-on-year change of 53.10.

What is the net investment of LB Pharmaceuticals Inc?

According to LB Pharmaceuticals Inc's FY2025 earnings report, its net investment of LB Pharmaceuticals Inc was -39.89M, with a year-on-year change of -271.68.

What is the net financing of LB Pharmaceuticals Inc?

According to LB Pharmaceuticals Inc's FY2025 earnings report, its net financing of LB Pharmaceuticals Inc was 302.56M, with a year-on-year change of 689.67.

What is the Earnings Per Share (EPS) of LB Pharmaceuticals Inc?

According to LB Pharmaceuticals Inc's FY2025 earnings report, its Earnings Per Share (EPS) was -1.00, with a year-on-year change of 64.57.

What is the net income of LB Pharmaceuticals Inc?

According to LB Pharmaceuticals Inc's FY2025 earnings report, its net income was -25.20M, with a year-on-year change of 60.06.

What is the Return on Assets (ROA) of LB Pharmaceuticals Inc?

According to LB Pharmaceuticals Inc's FY2025 earnings report, its Return on Assets (ROA) was -14.55, with a year-on-year change of 90.87.

What is the operating profit of LB Pharmaceuticals Inc?

According to LB Pharmaceuticals Inc's FY2025 earnings report, its operating profit was -30.40M, with a year-on-year change of 53.10.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.